CSIMarket Company Name, Ticker, Customers, else..
 
Ekso Bionics Holdings Inc   (NASDAQ: EKSO)
 

Ekso Bionics Holdings Inc's Suppliers Performance

EKSO's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
EKSO Costs vs Sales of Suppliers Growth Ekso Bionics Holdings Inc's cost of sales deteriorated by 0 % year on year, relative to one quarter ago cost of sales fell by -50 % in Q1.

• More on EKSO Suppliers



Ekso Bionics Holdings Inc's cost of sales deteriorated by 0 % year on year, compare to one quarter ago cost of sales fell by -50 % in Q1.

• More on EKSO Suppliers




Ekso Bionics Holdings Inc's Comment on Supply Chain


The company collaborates with Durable Medical Equipment (DME) suppliers who resell products to individual users and manage Medicare reimbursement processes that require physician prescriptions and medical necessity documentation. It has established a channel partner program involving Orthotics & Prosthetics (O&P) and DME partners to increase Medicare claims submissions and reimbursements. The company has entered into exclusive agreements with National Seating & Mobility in the Complex Rehabilitation Technology segment, Bionic Prosthetics & Orthotics Group, which serves 14 states, and Ottobock Patient Care, a national O&P provider. It continues to develop partnerships with additional regional and national O&P suppliers. Direct marketing efforts and sales backlog for the Ekso Indego Personal device have increased, with over 50 potential reimbursement candidates identified as of December 31, 2025.

Ekso Bionics Holdings Inc's Comment on Supply Chain


The company collaborates with Durable Medical Equipment (DME) suppliers who resell products to individual users and manage Medicare reimbursement processes that require physician prescriptions and medical necessity documentation. It has established a channel partner program involving Orthotics & Prosthetics (O&P) and DME partners to increase Medicare claims submissions and reimbursements. The company has entered into exclusive agreements with National Seating & Mobility in the Complex Rehabilitation Technology segment, Bionic Prosthetics & Orthotics Group, which serves 14 states, and Ottobock Patient Care, a national O&P provider. It continues to develop partnerships with additional regional and national O&P suppliers. Direct marketing efforts and sales backlog for the Ekso Indego Personal device have increased, with over 50 potential reimbursement candidates identified as of December 31, 2025.







EKSO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Ekso Bionics Holdings Inc 42.04 11.11 -15.69 31
SUBTOTAL 0.00 0.00 0.00 -


Sources: Ekso Bionics Holdings Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Ekso Bionics Holdings Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.